Akash Mourya | Health and Medicine Advances | Best Researcher Award

Published on by New Scientists

Mr. Akash Mourya | Health and Medicine Advances | Best Researcher Award

PhD Scholar | National Institutes of Pharmaceutical Education and Research | India

Mr. Akash Mourya is a promising young pharmacologist specializing in pharmacology and toxicology, with a strong research focus on liver pathophysiology, hepatoprotective drug discovery, and molecular mechanisms underlying hepatic and pulmonary disorders. His ongoing Ph.D. work at NIPER Mohali builds on extensive preclinical and translational research conducted at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, where he has developed expertise in animal models of liver diseases, hemodynamic studies, and hepatic cell culture systems. His research contributions have advanced understanding of non-alcoholic and alcoholic fatty liver diseases, hepatopulmonary and porto-pulmonary hypertension, and liver regeneration mechanisms. He has co-authored seven peer-reviewed publications in high-impact journals, including Journal of Hepatology, JHEP Reports, American Journal of Physiology–Gastrointestinal and Liver Physiology, npj Gut and Liver, ACS Omega, and Life Sciences. His work has collectively received 31 citations, 7 Documents, with an h-index of 3, reflecting growing recognition within the biomedical research community. In addition to journal articles, Mr. Akash Mourya has contributed two book chapters published by Springer Nature (2024) and Academic Press (2025), covering topics such as oxidative stress and pharmacological interventions in liver disease, and PPARγ signaling in diabetes. His research abstracts have been presented at prestigious international conferences, including the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL). His work integrates pharmacological innovation, molecular biology, and experimental therapeutics, with emphasis on Ayurvedic formulations, CB2 receptor agonists, and novel siRNA nanoparticle delivery systems. Mr. Akash Mourya’s ongoing efforts contribute to translational R&D for liver protection and regeneration, aligning with India’s growing emphasis on integrative pharmacology and precision medicine.

Profiles: Scopus | Google Scholar | ResearchGate | PubMed 

Featured Publications

1. Baweja, S., Kumari, A., Negi, P., Tomar, A., Tripathi, D. M., Mourya, A. K., Rastogi, A., Subudhi, P. D., Thangariyal, S., Kumar, G., Kumar, J., Sood, A., Vashistha, C., Bihari, C., Maiwall, R., & Sarin, S. K. (2023). Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. Journal of Hepatology, 79(1), 167–180.

2. Juneja, P., Rahman, S. N. R., Jakhar, D., Mourya, A. K., Tripathi, D. M., Kaur, I., Tiwari, V., & others. (2023). Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis. JHEP Reports, 5(10), 100816.

3. Biswas, S., Yadav, N., Juneja, P., Mourya, A. K., Kaur, S., Tripathi, D. M., & Chauhan, V. S. (2022). Conformationally restricted dipeptide-based nanoparticles for delivery of siRNA in experimental liver cirrhosis. ACS Omega, 7(41), 36811–36824.

4. Kaur, I., Juneja, P., Tiwari, R., Vasudevan, A., Mourya, A. K., Trauner, M., Sarin, S. K., & Tripathi, D. M. (2024). Secondary bile acids in portal blood contribute to liver regeneration in a rat model of partial hepatectomy. American Journal of Physiology – Gastrointestinal and Liver Physiology, 327(4), G645–G658.

5. Tripathi, D. M., Singh, P., Mourya, A. K., & Kaur, S. (2024). Oxidative medicine and novel pharmacological treatment approaches in liver disease. In Adaptation under stressful environments through biological adjustments and interventions (pp. 311–334). Springer Nature.

 

R Sagaya Jansi | Biotechnology | Best Researcher Award

Published on by New Scientists

DR. R Sagaya Jansi | Biotechnology | Best Researcher Award

Assistant Professor, Stella Maris College, India

Dr. R Sagaya Jansi is an Assistant Professor in the PG Department of Bioinformatics at Stella Maris College, India, where she has served as Head of the Department since November 2019 and currently coordinates the IQAC. She earned her Ph.D. in Biotechnology (Plant Biology and Plant Biotechnology) and an M.Phil. in Plant Biology and Plant Biotechnology from Loyola College, Chennai, India, along with an M.Sc. in Biotechnology from Loyola College and a B.Sc. in Advanced Zoology and Biotechnology from Stella Maris College. She has also cleared CSIR-NET (Life Sciences, 2018), SET (Life Sciences, 2012) and GATE (2011). Dr. Jansi’s research focuses primarily on plant biotechnology and the integration of bioinformatics in molecular modeling, computer-aided drug design, genomics, and proteomics, with emerging work bridging computational approaches and molecular biology to address challenges in biomedical and plant sciences. She has extensive teaching and research experience, having served as Assistant Professor at Loyola College, Research Assistant at the Bioinformatics Infrastructure Facility (DBT, Madras Christian College), and educator at Our Lady’s Matriculation Higher Secondary School, handling subjects including molecular biology, clinical research management, bioinformatics, programming in C++, and biophysics. Her key contributions include docking studies of bioflavonoids targeting anti-apoptotic pathways, development of bioinformatics infrastructure, and designing interdisciplinary educational programs that integrate biotechnology and computational biology. She has been recognized with the T. A. Venkateswaran Prize (II Rank, M.Sc.) and a Gold Medal (I Rank, M.Phil.), alongside multiple institutional awards for research and academic excellence. Dr. R Sagaya Jansi actively participates in academic societies, departmental leadership and IQAC coordination, mentoring students and contributing to curriculum development. Her work advances scientific understanding, fosters innovation, and supports global knowledge dissemination. Author metrics: 7 documents, 70 citations, h-index 4. With strong potential for international collaborations, Q1 publications, and research leadership, Dr. R Sagaya Jansi is highly deserving of recognition for advancing bioinformatics and biotechnology research excellence.

Profile: Scopus | ORCID | ResearchGate | Scispace | Stella Maris College | LinkedIn

Featured Publications

1. Sagaya Jansi, R., Khusro, A., Agastian, P., Kumar, G. A., Kadaikunnan, S., Khaled, J. M., & Thiruvengadam, M. (2024). Bioassay-guided fractionation and in vitro and in silico biological activities of 2,4-di-tert-butylphenol isolated from Nocardiopsis sp. strain LC-8. Chinese Journal of Analytical Chemistry.

2. Latha, R., Sarkar, T., Sagaya, J. R., & Agastian, P. (2015). Evaluation of antimicrobial efficiency and alpha-glucosidase inhibition of Rubus ellipticus Smith. leaf extracts and its phytochemical analysis. Asian Journal of Pharmaceutical and Clinical Research, 8(2), 422–426.

3. Latha, R., Saravana Kumar, P., Sagaya Jansi, R., Venkatadri, B., & Agastian, P. (2015). Antimicrobial efficacy and α-glucosidase inhibition of Passiflora mollissima Bailey leaves and its phytochemical analysis. International Journal of Pharmaceutical Research and BioScience, 4(4), 62–78.

4. Aparna, K., Sagaya Jansi, R., Arul Samraj, D., & Joyce PriyaKumari, C. (2013). Homology modelling and docking studies of phospholipase A2 enzyme of Apis mellifera. Journal of Current Pharmaceutical Research, 11(1), 33–37.

5. Joyce Priyakumari, C., Aparna, K., Sagaya Jansi, R., & Gladies Kezia. (2014). Phytochemical analysis of Didymocarpus pedicellatus. International Journal of Pharmaceutical Sciences Review and Research, 25(1), 307–309.